{"ticker": {"uuid": "d4a6f600-6ba9-4023-8b88-eb32961e4646", "symbol": "002332", "name": "Zhejiang Xianju Pharmaceutical Co.,Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Tranche Update on Zhejiang Xianju Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 14, 2026.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOblhjLVp3YlFNbnotWGI5QWdQLUtIZmowOHpGTkgxSnBzNWZSS2EtX1gwaHVzdm9tdjFsV05MaEZDQkYyckNzdjNYSFZLY25OVm9lM1JqQXJPRjdHTHRiMlh1TVFtcWpkSGsxRUxWSnl4U2M4NTJOc1pseEpmWGlOVy1Ed1FWTEpyQ3RNR1E0cXprV2hrZkFVTXB6NVZyZmtRS1ZCQUpDaXBMa000ZlVnaFk0d1NFb2cyLVVjanJsWGJSXy1sTDlVRl9HMUJXYXlyYzQ5NnFfTC1FWE9Xb1AwNlVaS1Y?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Zhejiang Xianju Pharmaceutical Co., Ltd. Class A \u2013 SZSE:002332", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYzdwTTN6QUZ1MXpQVlNKd2xLWUY5eThuRHVaTkZEYkVzWUFKajJDNGVNaEo2X0xGS2szS2preUZlc3B2WXdTQVJHN2hpMGpzUGhZTzZRWGoxRlpvSnVqa3ZSdGNNdEFFVlFnaU1qVl9sYUNDdk1MMUllTnNHWE84NnRMQV9EaDNWOTJQdjVicEZ2MEdrYUhGQnJReUdkd1BXZWkwc0xkdkJVd0U?oc=5", "source_name": "TradingView", "published_at": "2026-06-28T11:21:06+00:00", "published_display": "28 Jun 2026 11:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Tranche Update on Zhejiang Xianju Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 14, 2026.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOblhjLVp3YlFNbnotWGI5QWdQLUtIZmowOHpGTkgxSnBzNWZSS2EtX1gwaHVzdm9tdjFsV05MaEZDQkYyckNzdjNYSFZLY25OVm9lM1JqQXJPRjdHTHRiMlh1TVFtcWpkSGsxRUxWSnl4U2M4NTJOc1pseEpmWGlOVy1Ed1FWTEpyQ3RNR1E0cXprV2hrZkFVTXB6NVZyZmtRS1ZCQUpDaXBMa000ZlVnaFk0d1NFb2cyLVVjanJsWGJSXy1sTDlVRl9HMUJXYXlyYzQ5NnFfTC1FWE9Xb1AwNlVaS1Y?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Zhejiang Xianju Pharmaceutical Co., Ltd. Class A \u2013 SZSE:002332", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYzdwTTN6QUZ1MXpQVlNKd2xLWUY5eThuRHVaTkZEYkVzWUFKajJDNGVNaEo2X0xGS2szS2preUZlc3B2WXdTQVJHN2hpMGpzUGhZTzZRWGoxRlpvSnVqa3ZSdGNNdEFFVlFnaU1qVl9sYUNDdk1MMUllTnNHWE84NnRMQV9EaDNWOTJQdjVicEZ2MEdrYUhGQnJReUdkd1BXZWkwc0xkdkJVd0U?oc=5", "source_name": "TradingView", "published_at": "2026-06-28T11:21:06+00:00", "published_display": "28 Jun 2026 11:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 42, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "capital_return", "primary_label": "Capital return", "confidence": 58, "events": [{"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 8.58, "latest_week": "2026-07-17", "one_week_move": 4.0, "four_week_move": 3.6, "twelve_week_move": -1.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.33816, "market_dynamics_buy_signal": false, "relative_strength": -7.344106, "fair_value_gap": -13.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.0227, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.0% over one week, +3.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 50, "badges": [], "opportunities": [], "risks": [], "event_label": "Capital return", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Capital return", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Capital return", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.0% over one week, +3.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Tranche Update on Zhejiang Xianju Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 14, 2026."}], "updated_at": "2026-07-22T01:34:40.601405+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}